OAZ1
Ornithine decarboxylase antizyme 1
Also known as: AZ1, AZI, MGC138338, OAZ, OAZ1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P54368
- Gene
- OAZ1
- Ensembl
- ENSG00000104904
- Chromosome
- 19
- Canonical length
- 228 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Vesicles,Centriolar satellite
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene belongs to the ornithine decarboxylase antizyme family, which plays a role in cell growth and proliferation by regulating intracellular polyamine levels. Expression of antizymes requires +1 ribosomal frameshifting, which is enhanced by high levels of polyamines. Antizymes in turn bind to and inhibit ornithine decarboxylase (ODC), the key enzyme in polyamine biosynthesis; thus, completing the auto-regulatory circuit. This gene encodes antizyme 1, the first member of the antizyme family, that has broad tissue distribution, and negatively regulates intracellular polyamine levels by binding to and targeting ODC for degradation, as well as inhibiting polyamine uptake. Antizyme 1 mRNA contains two potential in-frame AUGs; and studies in rat suggest that alternative use of the two translation initiation sites results in N-terminally distinct protein isoforms with different subcellular localization. Alternatively spliced transcript variants have also been noted for this gene. [provided by RefSeq, Dec 2014]
Canonical amino-acid sequenceUniProt
228 residues, UniProt reviewed canonical sequence.
>P54368|OAZ1
1 MVKSSLQRIL NSHCFAREKE GDKPSATIHA SRTMPLLSLH SRGGSSSESS RVSLHCCSNP
61 GPGPRWCSDA PHPPLKIPGG RGNSQRDHNL SANLFYSDDR LNVTEELTSN DKTRILNVQS
121 RLTDAKRINW RTVLSGGSLY IEIPGGALPE GSKDSFAVLL EFAEEQLRAD HVFICFHKNR
181 EDRAALLRTF SFLGFEIVRP GHPLVPKRPD ACFMAYTFER ESSGEEEELocalizationUniProt · AlphaFold · HPA
Whether an antibody against OAZ1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 492 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 492 nTPM
- cerebral cortex: 337 nTPM
- amygdala: 322 nTPM
- bone marrow: 312 nTPM
- basal ganglia: 308 nTPM
- hippocampal formation: 305 nTPM
Single-cell type
- platelets: 6,104 nCPM
- megakaryocytes: 1,607 nCPM
- esophageal apical cells: 1,171 nCPM
- kupffer cells: 1,125 nCPM
- neutrophils: 1,104 nCPM
- hofbauer cells: 876 nCPM
Immune cell
- total PBMC: 2,796 nTPM
- neutrophil: 2,067 nTPM
- non-classical monocyte: 2,047 nTPM
- eosinophil: 1,944 nTPM
- basophil: 1,893 nTPM
- intermediate monocyte: 1,685 nTPM
Brain region
- hippocampal formation: 137 nTPM
- cerebral cortex: 122 nTPM
- basal ganglia: 119 nTPM
- midbrain: 118 nTPM
- hypothalamus: 114 nTPM
- medulla oblongata: 111 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.72
- gnomAD pLI
- 0.18
- gnomAD missense Z
- -0.87
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of polyamine transmembrane transport
- polyamine biosynthetic process
- positive regulation of intracellular protein transport
- positive regulation of protein catabolic process
- viral translational frameshifting
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of OAZ1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OAZ1 as an antibody target. Whether an autoantibody or antibody against OAZ1 could matter depends on whether native OAZ1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OAZ1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label OAZ1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...